Editorial · Longevity · NMN
NMN cost in the UK: per-month range
Oliver Mackman · Editorial director · Best Business Loans Ltd (16833937)
Published Tue Jun 02 2026 01:00:00 GMT+0100 (British Summer Time) · 5 min read
NMN (nicotinamide mononucleotide) is the cheapest way to encounter the NAD+ category in the UK, sold as a food-supplement capsule, powder or lozenge for a modest monthly outlay. The real cost depends on the per-capsule milligram count rather than the headline bottle price, because low-dose products look cheap until you account for how many capsules a daily serving needs. NMN sits well below the NAD+ injection and IV routes on price, but the routes are not comparable, because they differ on regulation and on what the early evidence supports. Prices move quickly, so treat ranges as orientation.
NMN pricing looks simple until you compare two bottles and realise the cheaper one is also the weaker one. This post explains how the per-capsule milligram count drives the real monthly cost, and where NMN sits against the other NAD+ routes. It is editorial commentary; figures move quickly, so treat the ranges as orientation rather than quotes. We do not sell NMN.
Why the headline price misleads
The number on the front of an NMN bottle is the least useful figure for comparing cost. What matters is the per-capsule milligram count and how many capsules make up a daily serving. A bottle that looks cheap can work out dearer once you account for a low milligram count that needs several capsules to reach the amount used in published trials. Our NMN label-reading post walks through where to find that figure on the packaging.
To compare two products fairly, work out the cost per month at a like-for-like milligram level rather than the cost per bottle. That single adjustment reorders most shortlists, and it is the reason the cheapest bottle on a retailer page is rarely the cheapest product in practice.
Where NMN sits on the NAD+ price ladder
Across the NAD+ category, the ingestible precursor route is the cheapest. NMN and NR sold as food supplements occupy the bottom of the ladder, a modest monthly outlay rather than a clinical bill. The NAD+ cost across routes post sets out the full ladder, but the short version is that supplements sit well below the injection and IV routes.
NAD+ injection courses are a private clinical service and cost more, and IV NAD+ is the most expensive, with multi-hour sessions usually sold as a course of several. The NMN supplement vs IV NAD+ comparison explains why those routes carry a different price and a different regulatory class, and why comparing them on price alone misses the point.
Form changes the per-gram cost
NMN is sold as capsules, loose powder and sublingual lozenges. Powder is usually the cheapest per gram but needs weighing and is less convenient. Capsules cost more per gram for the convenience of a fixed amount. Lozenges are marketed on absorption claims that the human evidence does not strongly support. None of these forms changes the legal status: all are food supplements under UK rules, as covered in the regulatory status post.
What the price does not buy
A higher price does not buy a proven health outcome. The human evidence for NMN is early, drawn from small short trials that report biomarker shifts rather than clinical benefits, with no large long-term randomised trials. Paying more for a premium brand may buy stated purity and batch testing, which are reasonable things to want, but it does not convert NMN into a medicine or a guaranteed result.
If you want the wider context before weighing cost, the NMN sub-hub is the parent page, and the UK longevity supplement landscape places NMN among the other supplements competing for the same shelf and the same budget. As always, speak to a healthcare professional before adding a supplement, especially alongside any existing medication.